Under the terms of the binding agreement, MCTC will private label its coffee products under the Sinister CBD brand name and other brands to be included in subsequent orders. The initial order is for hemp extract infused coffees packaged in single-serving coffee pods in 100% compostable packaging, including the coffee pod and the lid. MCTC expects to begin deliveries under the order during the month of March 2020.
„Hemp You Can Feel™ Coffee is a revolution in hemp and CBD infusion products,” commented Arman Tabatabaei, Chief Executive Officer. „Based on only the finest ingredients available anywhere in the marketplace, Hemp You Can Feel™ Coffee starts with ultra-premium organic coffee infused with our all-natural, patent-pending dual infusion process. 100% organic green coffee beans are imported from South America directly onsite and we supervise the roasting, grinding, CBD infusion and packaging right at our facility. We then package everything onsite in 100% compostable containers, including the pods and the lids. This green-bean-to-packaged product approach allows us to produce a superior product. We welcome Sinister CBD to the Hemp You Can Feel™ Family.”
The Company is utilizing its unique CBD infusion process for Hemp You Can Feel™ Coffee and all of its upcoming product offerings. Based on only natural ingredients, like trace amounts of organic vegetable oils, honey, and agave, the Company invented a unique process for all-natural CBD infusion using no chemicals. The Company has recently filed six patents on cannabinoid and hemp extract technologies and delivery systems. MCTC is currently working with patent counsel to protect various other aspects of its other new technologies and plans additional patent filings over the coming months.
MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.
www.CannabisGlobalinc.com.” data-reactid=”18″>More information on the Company can be viewed at www.CannabisGlobalinc.com.
www.sec.gov.” data-reactid=”22″>This news release contains „forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as „anticipate”, „seek”, intend”, „believe”, „estimate”, „expect”, „project”, „plan”, or similar phrases may be deemed „forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.